OliX PharmaceuticalsInc (226950) — Financial Flexibility Index
OliX PharmaceuticalsInc (226950) has a Financial Flexibility Index of -0.26x as of December 2025. Free cash flow of ₩-11.77 Billion (operating CF ₩-12.16 Billion minus capex ₩384.97 Million) represents 0% of total liabilities (₩45.29 Billion). Check how strategically is OliX PharmaceuticalsInc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OliX PharmaceuticalsInc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for OliX PharmaceuticalsInc across 10 annual periods. See working capital to net assets of OliX PharmaceuticalsInc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for OliX PharmaceuticalsInc (2016–2025)
Year-by-year free cash flow to debt coverage for OliX PharmaceuticalsInc. For the full company profile including market capitalisation, see 226950 company net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.31x | ₩-14.04 Billion | ₩-15.90 Billion | ₩45.29 Billion | ▼ -18.6% |
| 2024 | -0.26x | ₩-13.97 Billion | ₩-28.04 Billion | ₩53.40 Billion | ▼ -13.4% |
| 2023 | -0.23x | ₩-12.10 Billion | ₩-21.17 Billion | ₩52.49 Billion | ▲ +45.9% |
| 2022 | -0.43x | ₩-28.45 Billion | ₩-30.68 Billion | ₩66.74 Billion | ▼ -63.5% |
| 2021 | -0.26x | ₩-17.76 Billion | ₩-19.05 Billion | ₩68.15 Billion | ▼ -191.9% |
| 2020 | -0.09x | ₩-2.97 Billion | ₩-3.76 Billion | ₩33.29 Billion | ▲ +96.9% |
| 2019 | -2.85x | ₩-9.73 Billion | ₩-10.73 Billion | ₩3.41 Billion | ▲ +74.6% |
| 2018 | -11.24x | ₩-7.86 Billion | ₩-8.36 Billion | ₩698.94 Million | ▼ -845.8% |
| 2017 | -1.19x | ₩-3.52 Billion | ₩-4.79 Billion | ₩2.96 Billion | ▼ -1649.6% |
| 2016 | -0.07x | ₩-176.12 Million | ₩-3.45 Billion | ₩2.59 Billion | — |